Technological innovations and combination of external devices with pumps, government initiatives, improving healthcare infrastructure, and the large patient base and Rise in chronic diseases in geriatric population are key factors contributing to high CAGR during the forecast period.Market Size – USD 238.2 million in 2018, Market Growth - CAGR of 5.6%, Market Trends – Product launches and research for advanced products According to the current analysis of Reports and Data, the global Spinal pumps market was valued at USD 238.2 million in 2018 and is expected to reach USD 368.4 million by the year 2026, at a CAGR of 5.6 %.
ITDD systems consists of a catheter attached to a pump, and the pump is an external device or an implanted system that involves therapy and drug diagnosis.Spinal pumps market is driven by the rising prevalence of sclerosis, movement disorders, spinal and brain injuries, and cerebral palsy.
Technological innovations and combination of external devices with pumps that enable low medication dosages accelerates the market growth for the forecast period.Favorable government initiatives, improving healthcare infrastructure, and the large patient base, is projected to support the spinal pump industrial growth in developing regions such as India and China.
Some of the side effects, such as a fluid leak, severe skin reactions, and headache, are expected to hamper market growth.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2191The report provides a complete analysis of the global Spinal Pumps market with important details about the key market players from insightful primary and secondary research data.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: DePuy Synthes, FlowonixMedical, Inc., Medtronic Plc, Tricumed Medizintechnik GmbH, and Teleflex, Inc.Further key findings from the report suggestIntrathecal baclofen (ITB) pump implantation can be used to control dystonia and severe pain associated with complex regional pain syndrome (CRPS).
Intrathecal baclofen (ITB) pumps have been used to ameliorate global pain in patients with CRPS and dystonia based on the anti-nociceptive effects of ITB.Medtronic plc and Samsung Electronics Co., Ltd. declared their collaborative agreement to develop health solutions in the area of neuromodulation.The pain management category led the application segment of this industry with the largest revenue share at over 69.4%, due to to the increasing preference for long-term relief alternatives and the high prescription prices associated with conventional opioid drugs used in pain management.Spasticity management is growing at the fastest CAGR at over 3.8% throughout the forecast period.